Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCardiovascular

Acute Myocardial Infarction Inhibits the Neurogenic Tachycardic and Vasopressor Response in Rats via Presynaptic Cannabinoid Type 1 Receptor

Radosław Rudź, Eberhard Schlicker, Urszula Baranowska, Justyna Marciniak, Piotr Karabowicz and Barbara Malinowska
Journal of Pharmacology and Experimental Therapeutics October 2012, 343 (1) 198-205; DOI: https://doi.org/10.1124/jpet.112.196816
Radosław Rudź
Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland (R.R., U.B., J.M., P.K., B.M.); and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (E.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eberhard Schlicker
Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland (R.R., U.B., J.M., P.K., B.M.); and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (E.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urszula Baranowska
Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland (R.R., U.B., J.M., P.K., B.M.); and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (E.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justyna Marciniak
Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland (R.R., U.B., J.M., P.K., B.M.); and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (E.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piotr Karabowicz
Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland (R.R., U.B., J.M., P.K., B.M.); and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (E.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Malinowska
Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland (R.R., U.B., J.M., P.K., B.M.); and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (E.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 343 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 343, Issue 1
1 Oct 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Acute Myocardial Infarction Inhibits the Neurogenic Tachycardic and Vasopressor Response in Rats via Presynaptic Cannabinoid Type 1 Receptor
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCardiovascular

Myocardial Infarction and CB1 Receptors

Radosław Rudź, Eberhard Schlicker, Urszula Baranowska, Justyna Marciniak, Piotr Karabowicz and Barbara Malinowska
Journal of Pharmacology and Experimental Therapeutics October 1, 2012, 343 (1) 198-205; DOI: https://doi.org/10.1124/jpet.112.196816

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCardiovascular

Myocardial Infarction and CB1 Receptors

Radosław Rudź, Eberhard Schlicker, Urszula Baranowska, Justyna Marciniak, Piotr Karabowicz and Barbara Malinowska
Journal of Pharmacology and Experimental Therapeutics October 1, 2012, 343 (1) 198-205; DOI: https://doi.org/10.1124/jpet.112.196816
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Immunoliposome-Based Targeting of Endothelial RhoA Signaling
  • Anakinra dispensed in plastic vs glass syringes
  • The effect of Dexmedetomidine on PAH improvement
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics